Striking study results last year indicated a new type of medicine may improve on Merck’s immunotherapy, spurring a wave of ...

A new review article published in Genes & Diseases sheds light on the complex molecular mechanisms through which ...

Reverb Therapeutics, a leader in harnessing the natural immune system and cytokine signaling to treat life-threatening diseases, announced it has closed a $17.2 million (USD $12 Million) financing led ...